CNK - Taylor Swift's Concert Film & Beyoncé's Documentary: How They're Setting Cinemark Up for A Breakout Q4 Says Analyst | Benzinga
Benchmark analyst Mike Hickey reiterated a Buy rating on the shares of Cinemark Holdings Inc (NYSE: CNK) and raised the price target from $21 to $22.
The analyst has revised the Q3 sales estimate upwards to $833 million as box office results have surpassed initial forecasts.
In 3Q 2023, the domestic box office grossed $2.65 billion, a 37.6% increase from 2022, with Barbie leading the charge.
The analyst sees an AEBITDA of $180 million, a 21.6% margin, surpassing the consensus of $153 million at 19.6%, backed by ...